Human plasma concentrations of cytochrome P450 probes extrapolated from pharmacokinetics in cynomolgus monkeys using physiologically based pharmacokinetic modeling

References

• Amidon GL, Sinko PJ, Fleisher D. (1988). Estimating human oral fraction dose absorbed: a correlation using rat intestinal membrane permeability for passive and carrier-mediated compounds. Pharm Res 5:651–4
   PubMed Web of Science ®Google Scholar
• Capon DA, Bochner F, Kerry N, et al. (1996). The influence of CYP2D6 polymorphism and quinidine on the disposition and antitussive effect of dextromethorphan in humans. Clin Pharmacol Ther 60:295–307
   PubMed Web of Science ®Google Scholar
• Davies B, Morris T. (1993). Physiological parameters in laboratory animals and humans. Pharm Res 10:1093–5
   PubMed Web of Science ®Google Scholar
• Edwards SW, Preston RJ. (2008). Systems biology and mode of action based risk assessment. Toxicol Sci 106:312–18
   PubMed Web of Science ®Google Scholar
• Emoto C, Murayama N, Rostami-Hodjegan A, Yamazaki H. (2009). Utilization of estimated physicochemical properties as an integrated part of predicting hepatic clearance in the early drug-discovery stage: impact of plasma and microsomal binding. Xenobiotica 39:227–35
   PubMed Web of Science ®Google Scholar
• Gargas ML, Andersen ME, Teo SKO, et al. (1995). A physiologically based dosimetry description of acrylonitrile and cyanoethylene oxide in the rat. Toxicol Appl Pharmacol 134:185–94
   PubMed Web of Science ®Google Scholar
• Iwasaki K, Uno Y. (2009). Cynomolgus monkey CYPs: a comparison with human CYPs. Xenobiotica 39:578–81
   PubMed Web of Science ®Google Scholar
• Jamei M, Marciniak S, Feng K, et al. (2009). The Simcyp population-based ADME simulator. Expert Opin Drug Metab Toxicol 5:211–23
   PubMed Web of Science ®Google Scholar
• Kato M, Shitara Y, Sato H, et al. (2008). The quantitative prediction of CYP-mediated drug interaction by physiologically based pharmacokinetic modeling. Pharm Res 25:1891–901
   PubMed Web of Science ®Google Scholar
• Koyanagi T, Nakanishi Y, Murayama N, et al. (2015). Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole, and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation. Xenobiotica. [Epub ahead of print]. doi: 10.3109/00498254.2014.979271
   PubMed Web of Science ®Google Scholar
• Oh KS, Park SJ, Shinde DD, et al. (2012). High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 895–6:56–64
   Web of Science ®Google Scholar
• Ohtsuka T, Yoshikawa T, Kozakai K, et al. (2010). Alprazolam as an in vivo probe for studying induction of CYP3A in cynomolgus monkeys. Drug Metab Dispos 38:1806–13
   PubMed Web of Science ®Google Scholar
• Poulin P, Haddad S. (2013). Hepatocyte composition-based model as a mechanistic tool for predicting the cell suspension: aqueous phase partition coefficient of drugs in in vitro metabolic studies. J Pharm Sci 102:2806–18
   PubMed Web of Science ®Google Scholar
• Poulin P, Theil FP. (2002). Prediction of pharmacokinetics prior to in vivo studies. 1. Mechanism-based prediction of volume of distribution. J Pharm Sci 91:129–56
   PubMed Web of Science ®Google Scholar
• Rendic S, Guengerich FP. (2012). Contributions of human enzymes in carcinogen metabolism. Chem Res Toxicol 25:1316–83
   PubMed Web of Science ®Google Scholar
• Ryu JY, Song IS, Sunwoo YE, et al. (2007). Development of the “Inje cocktail” for high-throughput evaluation of five human cytochrome P450 isoforms in vivo. Clin Pharmacol Ther 82:531–40
   PubMed Web of Science ®Google Scholar
• Sakai C, Iwano S, Yamazaki Y, et al. (2014). Species differences in the pharmacokinetic parameters of cytochrome P450 probe substrates between experimental animals, such as mice, rats, dogs, monkeys, and microminipigs, and humans. J Drug Metab Toxicol 5:173
   Google Scholar
• Suemizu H, Sota S, Kuronuma M, et al. (2014). Pharmacokinetics and effects on serum cholinesterase activities of organophosphorus pesticides acephate and chlorpyrifos in chimeric mice transplanted with human hepatocytes. Regul Toxicol Pharmacol 70:468–73
   PubMed Web of Science ®Google Scholar
• Tsukada A, Suemizu H, Murayama N, et al. (2013). Plasma concentrations of melengestrol acetate in humans extrapolated from the pharmacokinetics established in in vivo experiments with rats and chimeric mice with humanized liver and physiologically based pharmacokinetic modeling. Regul Toxicol Pharmacol 65:316–24
   PubMed Web of Science ®Google Scholar
• Turpault S, Brian W, Van HR, et al. (2009). Pharmacokinetic assessment of a five-probe cocktail for CYPs 1A2, 2C9, 2C19, 2D6 and 3A. Br J Clin Pharmacol 68:928–35
   PubMed Web of Science ®Google Scholar
• Yamashita M, Suemizu H, Murayama N, et al. (2014). Human plasma concentrations of herbicidal carbamate molinate extrapolated from the pharmacokinetics established in in vivo experiments with chimeric mice with humanized liver and physiologically based pharmacokinetic modeling. Regul Toxicol Pharmacol 70:214–21
   PubMed Web of Science ®Google Scholar
• Zadoyan G, Rokitta D, Klement S, et al. (2011). Effect of Ginkgo biloba special extract EGb 761(R) on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers. Eur J Clin Pharmacol 68:553–60
   PubMed Web of Science ®Google Scholar